z-logo
open-access-imgOpen Access
Minimizing side effects, maximizing returns: what makes a smart therapeutic design?
Author(s) -
Jungmin Lee,
Katherine Redfield,
Jeffrey C. Way,
Pamela A. Silver
Publication year - 2019
Publication title -
the biochemist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 7
eISSN - 1740-1194
pISSN - 0954-982X
DOI - 10.1042/bio04103028
Subject(s) - side effect (computer science) , medicine , biology , cancer research , computer science , programming language
Symptoms of cancer can be devastating. However, the side effects of cancer treatments aimed at leaving the patient tumour-free, often inflict their own brutal attack on the body. The same treatments that kill rapidly dividing tumour cells will just as easily kill any other rapidly dividing cells in the body, wreaking havoc on the lining of our intestines, our replenishing blood cells and our usually industrious hair follicles. This is an extreme example of a common problem: drugs have frequent, unintended and largely unpleasant side effects as a result of indiscriminate binding to both their desired targets and a multitude of other sites. How can synthetic biologists help?

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom